Prothera, Inc.
Records under this name other than patents Prothera, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,737,591 | Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis Lapsed on the fee record Ended Aug 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2025 | From the USPTO record |
| US 11,078,516 | Inhibition and treatment of gastrointestinal biofilms Lapsed on the fee record Ended Aug 3, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 3, 2025 | From the USPTO record |
| US 9,579,353 | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes Lapsed on the fee record Ended Feb 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 28, 2025 | From the USPTO record |
| US 8,383,101 | Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions Lapsed on the fee record Ended Feb 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2025 | From the USPTO record |
| US 9,358,274 | Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions Lapsed on the fee record Ended Jun 7, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2024 | From the USPTO record |
| US 9,987,337 | Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions Lapsed on the fee record Ended Jun 5, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2022 | From the USPTO record |
| US 8,728,467 | Methods comprising serratia peptidase for inhibition of osteomyelitis Lapsed on the fee record Ended May 20, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 20, 2022 | From the USPTO record |
| US 9,931,381 | Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions Lapsed on the fee record Ended Apr 3, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2022 | From the USPTO record |
| US 9,387,236 | Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases Lapsed on the fee record Ended Jul 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jul 12, 2020 | From the USPTO record |
| US 6,808,708 | Compositions and methods relating to reduction of symptoms of autism Term ended Term ended Apr 17, 2020 · From the USPTO record | Term ended | Term ended Apr 17, 2020 | From the USPTO record |